- Home
- CLST vs NRXS Comparison
CLST vs NRXS Comparison
Compare CLST & NRXS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Company Overview
Basic Information| Metric | CLST | NRXS |
|---|---|---|
| Founded | 1922 | 2011 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | | |
| Sector | | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 70.0M | 78.9M |
| IPO Year | 2021 | 2023 |
Fundamental Metrics
Financial Performance| Metric | CLST | NRXS |
|---|---|---|
| Price | $17.81 | $5.96 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $13.00 |
| AVG Volume (30 Days) | 2.5K | ★ 80.5K |
| Earning Date | 04-30-2026 | 05-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 171.79 | 22.13 |
| EPS | ★ 0.30 | N/A |
| Revenue | N/A | ★ $3,569,282.00 |
| Revenue This Year | N/A | $172.91 |
| Revenue Next Year | N/A | $115.71 |
| P/E Ratio | $58.37 | ★ N/A |
| Revenue Growth | N/A | ★ 32.89 |
| 52 Week Low | $13.00 | $2.21 |
| 52 Week High | $20.50 | $9.33 |
Technical Indicators
Market Signals| Indicator | CLST | NRXS |
|---|---|---|
| Relative Strength Index (RSI) | 56.60 | 42.39 |
| Support Level | $16.28 | $6.04 |
| Resistance Level | $18.16 | $7.37 |
| Average True Range (ATR) | 0.41 | 0.24 |
| MACD | 0.01 | -0.00 |
| Stochastic Oscillator | 10.75 | 43.89 |
Price Performance
Historical ComparisonAbout CLST Catalyst Bancorp Inc.
Catalyst Bancorp Inc is a bank holding company. Through its subsidiary, which is a federally chartered community-oriented savings bank, it is engaged in attracting deposits from the general public and using those funds to invest in loans and securities. The sources of funds are customer deposits, repayments of loans, maturities of investments, and funds borrowed from outside sources, which are used for the origination of loans. It operates in one reportable segment, which generates income principally from interest on loans and investment securities, as well as from fees charged in connection with various loan and deposit services.
About NRXS Neuraxis Inc.
Neuraxis Inc is a growth stage company is engaged in developing neuromodulation therapies to address chronic and debilitating conditions in children. The company is dedicated to advancing the science with its' proprietary Percutaneous Electrical Nerve Field Stimulation (PENFS) technology. The company focuses on targeted therapies for the pediatric and adolescent population suffering from disorders of gut-brain interaction (DGBIs).